Concepedia

G. Ruiter

GR

Statistics

Publications

5

Citations

315

H-Index

5

Active since

1999

Affiliations

Institut Curie(Current)

Yonsei University

National Cancer Center Hospital East

Oncode Institute

Institut Gustave Roussy

G. Ruiter is an author at Institut Curie specializing in oncology, apoptosis, and signal transduction.

Publications per year

1999–2025

5

Publications

5

Alkyl-lysophospholipids activate the SAPK/JNK pathway and enhance radiation-induced apoptosis.

G. Ruiter, Shuraila F. Zerp, Harry Bartelink et al. · PubMed · 1999 · 153 citations

, , +17

Zongertinib in Previously Treated <i>HER2</i> -Mutant Non–Small-Cell Lung Cancer

John V. Heymach, G. Ruiter, Myung‐Ju Ahn et al. · New England Journal of Medicine · 2025 · 88 citations

, , +16

Sevabertinib in Advanced <i>HER2</i> -Mutant Non–Small-Cell Lung Cancer

Xiuning Le, Tae Min Kim, Herbert H. Loong et al. · New England Journal of Medicine · 2025 · 39 citations · Full text

, , +14

Alkyl-lysophospholipids activate the SAPK/JNK signaling pathway and enhance radiation-induced apoptosis

G. Ruiter, Shuraila F. Zerp, Harry Bartelink et al. · European Journal of Cancer · 1999 · 19 citations

, , +12

1313MO Safety and preliminary efficacy of AZD7789, a bispecific antibody targeting PD-1 and TIM-3, in patients (pts) with stage IIIB–IV non-small-cell lung cancer (NSCLC) with previous anti-PD-(L)1 therapy

Benjamin Besse, Antoine Italiano, Sophie Cousin et al. · Annals of Oncology · 2023 · 16 citations · Full text

, , +16

1–5 of 5